The US Department of Defence has invested $46 million to develop a blood substitute
The US Department of Defence's Defence Advanced Research Projects Agency (DARPA) has invested $46 million to develop a synthetic human blood product, ErythroMer, which has shown good results in preclinical studies in the spring of 2024
10.07.2024